Virtual teaching sessions delivered COVID-19 outbreak
| Speciality | Topic |
|---|---|
| Cardiology | Cardiac complications in COVID-19 Thrombotic events in COVID-19 |
| Diabetes and endocrine | Addison's disease Diabetic emergencies Hyponatraemia Thyrotoxicosis and thyroid storm Update in type II diabetes |
| Emergency department | Conversation between ED and intensive care unit: learning from the intensive care unit |
| Health services for elderly care (HSEP) | Delirium and COVID-19 Frailty and COVID-19 |
| Infectious diseases | Clinical trials COVID-19 care bundle Guidance on antibiotic prescribing in COVID-19 Learning from COVID-19 experience in Hong Kong Personal protective equipment |
| Infectious diseases journal club | Antibodies in COVID-19: diagnostic and therapeutic uses A trial of lopinavir-ritonavir in adults hospitalised with severe COVID-19 Clinical course and risk factors for mortality of adult inpatients with COVID-19 Exploring COVID-19 mortality in the black, Asian and minority ethnic groups SARS-CoV-2 viral loads and the assessment of hydroxychloroquine The challenge of asymptomatic transmission in COVID-19 The effect of social distancing measures on transmission of SARS-CoV-2 |
| Intensive care | Conversation between ED and intensive care unit: learning from the intensive care unit Mechanical ventilation Pulmonary and renal complications in COVID-19 |
| Medical education | Wellbeing |
| Medical Examiner Officer | Guidance on completion of a medical certificate of death (MCCD) |
| Ophthalmology | COVID-19 Eye-CU |
| Palliative medicine | Breaking bad news Cornea donation End of life care |
| Physiotherapy | Proning in COVID-19 |
| Psychiatry | Resilience during COVID-19 |
| Radiology | Chest X-ray interpretation in COVID-19 General CT interpretation |
| Renal | ACEi/ARBs and COVID-19 COVID-19 and the kidney Pulmonary and renal complications in COVID-19 |
| Respiratory | Continuous positive airway pressure therapy (CPAP) COVID-19 respiratory follow-up Oxygen delivery in COVID-19 |
| Rheumatology | COVID-19 and the cytokine storm |
| Senior management team | In conversation with the chief executive |